Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00089804
Other study ID # LJP 394-90-14
Secondary ID
Status Terminated
Phase Phase 3
First received August 13, 2004
Last updated March 30, 2009
Start date October 2004
Est. completion date February 2009

Study information

Verified date March 2009
Source La Jolla Pharmaceutical Company
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to determine whether abetimus sodium is more effective than placebo in delaying time to renal flare in SLE patients with a history of renal disease.


Recruitment information / eligibility

Status Terminated
Enrollment 943
Est. completion date February 2009
Est. primary completion date February 2009
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 70 Years
Eligibility Inclusion Criteria:

- Diagnosis of Systemic Lupus Erythematosus (SLE)

- Active SLE renal disease within past 4 years.

- Males or females between 12 and 70 years old.

- Females must be non-pregnant and non-lactating. Females and males must use adequate birth control methods during course of study.

- Ability to have weekly intravenous (IV) administration of study treatment.

Exclusion Criteria:

- Active SLE renal disease within past 3 months prior to entering study.

- Use of the following therapies within 3 months prior to entering the study: alkylating agents, e.g., cyclophosphamide, TNF inhibitors, cyclosporine.

- Use of mycophenolate mofetil that exceeds 1000 mg/day, azathioprine that exceeds 100 mg/day, methotrexate that exceeds 10 mg/week, leflunomide that exceeds 10 mg/day within 2 months prior to entering study.

- Use of rituximab within 6 months prior to entering study.

- Current abuse of drugs or alcohol.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
abetimus sodium (LJP 394) and/or placebo solution
300 mg (50 mg/mL)abetimus sodium (three 2 mL vials of of abetimus sodium plus six 2 mL vials of normal saline) administered i.v. (in the vien) weekly for 52 weeks
abetimus sodium (LJP 394)
900 mg (50 mg/mL) abetimus sodium (nine 2 mL vials) administered i.v. (in the vien) weekly for 52 weeks.
Phosphate-buffered saline
A volume of 18 mL (nine 2 mL vials of normal saline) of identically appearing placebo (phosphate-buffered saline) administered i.v. (in the vien) weekly for 52 weeks

Locations

Country Name City State
Argentina Centro de Investigaciones en Enfermedades Reumaticas (CIER) Buenos Aires
Argentina Centro de Investigaciones Reumatologicas y Osteologicas Buenos Aires
Argentina CIR Hospital Sirio Libanes. Campana 4658 Buenos Aires Ciudad Autonma de
Argentina Organización Médica de la Investigación Buenos Aires Uruguay 725 P.B.
Argentina Unidad de Alergia, Asma e Inmunología Clínica Buenos Aires
Argentina Investigación Clínica Polivalente La Plata
Argentina Instituto CAICI Rosario Santa Fe
Argentina Centro de Investigaciones Reumatológicas San Miguel de Tucumán Provincia de Tucumán
Australia Rheumatology Clinic Cairns
Australia Dept Medicine, Level 3 Wallace Freeborn Building, Royal North Shore Hospital, Pacific Highway St Leonards
Australia Vincents Hospital Daly Building, 41 Victoria Parade Fitzroy Victoria
Belarus Gomel Regional Clinical Hospital Gomel
Belarus Minsk City Clinical Hospital # 164 Minsk
Belarus Minsk City Clinical Hospital # 2 Minsk
Belarus Minsk City Clinical Hospital # 9 Minsk
Belarus Minsk Regional Clinical Hospital Minsk
Belarus Vitebsk Regional Clinical Hospital Vitebsk
Brazil Santa Casa de Misericórdia de BeloHorizonte, Av. Francisco Sales, n. 1111 9 andar Ala D/ CCIH Belo Horizonte Minas Gerais
Brazil Hospital e Maternidade Celso Pierro - PUCCampinas, Av. John Boyd Dunlop, s/n Campinas - Sao Paulo
Brazil Hospital de Clinicas - Universidade Estadual de Campinas - UNICAMP, Rua Vital Brasil, 250 - 3º andar - Cidade Universitária Zeferin Campinas - SP
Brazil Athritis Clinica de Doenças Reumaticas, Av. Padre Anchieta, 1846 cj 1108 Curitiba - PR
Brazil Hospital das Clinicas da Faculdade de Medicina da Universidade, Federal de Goiás, Servico de Reumatologia / 2 andar Goiänia, Goiás Primeira Avenida s/n Setor Universitário
Brazil Hospital Geral de Goiania, GO Av Anhanguera 6479 Setor Oeste Goiania-GO Goias
Brazil Hospital de Clinicas de Porto Alegre - HCPA Porto Alegre-RS
Brazil Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul-PUCRS Porto Alegre-RS Av. Ipiranga, 6690-Conj. 220-Jardim Botanico
Brazil Hospital das Clínicas of Medicine School of University of São Paulo (USP) at Ribeirão Preto Rheumatology Department Avenida dos Ribeirão Preto
Brazil Hospital Universitario Pedro Ernesto Rio de Janeiro Avenida 28 de Setembro, 77
Brazil Hospital Santa Izabel, Praca Almeida Couto, 500 - Naxaré Salvador - BA
Brazil Hospital Hehopolis Sao Paulo Avenida Almirante Delamare, 1534-Sacoman
Brazil Irmandade da Santa Casa de Misericórdia de Sao Paulo Rua, Dr. Cesário Motta Junior, 112 São Paulo
Brazil Rua Pedro de Toledo 1800 9 andar/ Ala central - Diretoria de Servico de Reumatologia Sao Paulo - SP
Bulgaria MHAT "Sveti Georgi", Clinic of Rheumatology Plovdiv 15A "Vasil Aprilov" blvd.
Bulgaria Clinic of Nephrology, MHAT "Alexandrovska" 1, Georgi Sofiiski, str., Sofia
Bulgaria MHAT "Sveti Ivan Rilski", Clinic of Rheumatology Sofia 13 "Urvich" Street
Bulgaria Military Medical Academy, Clinic of Urology and Nephrology Sofia 3, Georgi Sofiiski, str.
Bulgaria NMTranspH "Tsar Boris Treti", Clinic of Internal Diseases Sofia 104 "Maria Louisa" blvd.
Bulgaria MHAT "Stara Zagora", Second Clinic of Internal Diseases Stara Zagora 11 "Armeiska" street
Czech Republic Fakultni nemocnice Plzen, Oddeleni klinické farmakologie Plzen Edvarda Benese
Czech Republic Revmatologický ústav Praha 2
Czech Republic VFN Prahal Lékarská fakulta, Klinika detského a dorostového lékarstvi, Praha 2 Ke Karlovu, 09 Praha 2,
Georgia Academic VL Tsitlanadze Scientific - Practical Center of Rheumatology Tbilisi
Germany Herz and Rheumazentrum Kerckhoff-klinik GmbH Bad Nauheim Benekestrasse 2-8
Germany Charité-Unversitätmedizin Berlin, CharitéCentrum Inn ere Medizin und Dermatologie Berlin Chariteplatz 1
Germany Georg August Universität Göttingen Universitätsklinikum, Zentrum Innere Medizin Göttingen Robert-Kochstr. 40
Germany Medizinische Klinik und Poliklinik IV des Universitätsklinikum Lepizig, Rheumatologie Leipzig Liebigstrasse 22
Germany Johannes Gutenberg-Universität I. Medizinische Klinik und Poliklinik,Langenbeckstr. 1 Mainz
Hong Kong Hong Kong University, Queen Mary Hospital Hong Kong
Hong Kong The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong
Hungary Diagnostic Units Hungary Kft. Budapest
Hungary Szent László Kórház, VI. Fertozo Belosztály Budapest
Hungary Szent Margit Hospital, Department of Nephrology Budapest
Hungary Debrecen Medical University Debrecen
Hungary Petz Aladar Megyei Oktato Korhaz, Immunnephrologia es Hypertonia Osztaly Gyor
India Institute of Kidney Diseases and Research (IKRD) and Institute of Transplantation Sciences (ITS) Ahmedabad Asarwa
India M.S. Ramaiah Memorial Hospital Bangalore Karnataka
India St. Johns Medical College and Hospital, Dept. of Nephrology Bangalore Karnataka
India Post Graduate Institute of Medical Education and Research Chandigarh
India Devaki Hospital Ltd., Dept. of Nephrology Chennai
India Madras Institute of Nephrology, Vijaya Health Center Chennai
India Spectra Apollo Research Foundation Chennai
India PVS Memorial Hospital Ltd. Cochin Kaloor, Kerala
India Consultant and Head Department of Nephrology, Kamineni Hospitals Hyderabaad L.B. Nagar
India Global Hospitals Hyderabaad Andhra Pradesh
India Medwin Hospital Hyderabaad
India Nizams Institute of Medical Sciences Hyderabaad
India Department of Nephrology, CARE Hospital, Banjara Hills Hyderabad
India M.P. Shah Medical College & G.G. Hospital Jamnagar Gujarat
India Amrita Institute of Medical Sciences Kochin Kerala
India Armenian Church Trauma Center - Unit of Rabindranath Tagore International Institute of Cardiac Sciences Kolkata
India Apollo Gleneagles Hospital Kolkatta Kankurgachi
India Sanjay Ghandi Post Graduate Institute of Medical Sciences Lucknow
India Apollo Specialty Hospitals, Lake View Road, K.K., Nagar Madurai Tamil Nadu
India BYL Nair Charitable Hospital & TN Medical College Mumbai
India P.D. Hinduja National Hospital and Research Center Mumbai
India Seth G.S. Medical College & KEM Hospital Mumbai
India Department of Nephrology, JSS Hospital, Ramanuja Road Mysore
India Department of Nephrology, All India Institute of Medical Sciences New Delhi Ansari Nagar
India Indraprastha Apollo Hospital New Delhi
India Fortis Hospital, Dept. of Nephrology & Hypertension Noida Uttar Pradesh
India Sri Ramachandra Medical College & Research Institute (Deemed University) Porur Chennai
India Jehangir Hospital, 32 Sassoon Road Pune
India Medical College Trivandrum Trivandrum
India King George Hospital Visakhapatnam
Indonesia RS Hasan Sadikin Bandung Jl. Pasir Kaliki No. 190, Jawa Barat
Indonesia RS Kramat 128 Jakarta Jl. Kramat Raya, Pusat
Indonesia Dept. of Internal Medicine, Saiful Anwar General Hospital Malang Jl. J.A. Suprapto No. 2
Italy Arcispedale S. Anna, Divisione di Reumatologia Ferrara Corso Giovecca 203
Italy Azienda Ospedaliera Cattedra di Reumatologia Padova Via Giustiniani, 2
Italy Universita di Pisa, Dipartimento di Medicina Interna Pisa Via Roma 67
Korea, Republic of Inha University Hospital In Cheon
Korea, Republic of Bundang Cha General Hospital, Pochon Cha University Kyonggi-do
Korea, Republic of Pusan National University Hospital Pusan
Korea, Republic of Ewha Woman's University College of Medicine, Mockdong Hospital Seoul Yangcheon-Gu
Korea, Republic of Kangnam St. Mary's Hospital, Catholic University of Korea Seoul
Korea, Republic of Seoul National University Hospital, Department of Internal Medicine Seoul
Korea, Republic of St. Mary's Hospital, Catholic University of Korea Seoul
Korea, Republic of The Hospital for Rheumatic Disease, Hanyang University Medical Center Seoul
Korea, Republic of Ajou University Medical Center, Ajou University School of Medicine Suwon
Lebanon Albert Haykel Hospital Haykaliyeh-Tripoli
Lebanon Nabatieh Governmental Hospital Nabatieh
Lebanon Rayak Hospital Rayak Bekaa Valley
Lebanon Hammoud Hospital University Medical Center Saida
Lebanon Labib Medical Center Saida
Malaysia Department of Medicine, Hospital Pulau Pinang, Pulau Pinang Jalan Residensi
Malaysia CAPD Unit, Queen Elizabeth Hospital, Sabah Kota Kinabalu
Malaysia Department of Medicine, Sarawak General Hospital, Jalan Tun Ahmad Zaidi Adruce, Sarawak Kuching
Mexico Poliplaza Medica Chihuahua
Mexico Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran", Departmento de inmunologia y Reumatologia Delagacion Tlalpan D.f.
Mexico Centro de Estudios de Investigación Básica y Clínica S.C. Guadalajara Jalisco
Mexico Colomos #2292, Col. Providencia Guadalajara Jalisco
Mexico Hospital Aranda de la Parra Leon Guanajuato
Mexico Reumatologia Mexicali
Mexico Clínica de Diagnóstico y Tratamiento de las Enfermedades Reumáticas Mexico City D.f.
Mexico Hospital Star Medica Morelia Michoacan
Mexico Hospital Privado San José de Ciudad Obregón, S.A. de C.V. Coahuila No. 263 Sur. Col. Centro. Ciudad Obregón Sonora
Mexico Blvd. Sanchez Taboada 9250-28 - Private Practice Tijuana Baja California
Philippines Chung Hua Hospital Cebu
Philippines Davao Doctors Hospital Davao
Philippines Joint and Bone Center, University of Santo Tomas Hospital Manila
Philippines Philippine General Hospital Manila
Poland Klinika Nefrologii, Transplantologii i Chorob Wewnetrznych - Akademickie Centrum Kliniczne - Szpital AMG Gdansk
Poland Klinika Chorob Wewnetrznych i Reumatologii - Gornoslaskie Centrum Medyczne, SPSK Nr 7 SL A M Katowice
Poland Oddzial Kiliniczny Nefrologii Hipertensjologii i Transplantologii Nerek SPZOZ, Uniwersytecki Szpital Kliniczny nr 1 Lodz
Poland Klinika Reumatologii i Ukladowych Chorob Tkanki Lacznej Lublin
Poland Akademii Medycznej w Poznaniu, Zaklad Reumatologii i Immunologii Klinicznej Poznan
Poland Klinika Chorób Tkanki Lacznej Warszawa
Poland Klinika Medycyny, Transplantacyjnej i Nefrologii in Warszawa, Nowogrodzka 59, At SPZOZ Szpital Kliniczny Warszawa Dzieciatka Jezus-Centrum Leczenia Obrazen, Lindleya 4
Poland Klinika Nefrologii Dializoterapii I Chorob Wewnetrznych - Samodzielny Publiczny Centralny Szpital Kliniczny Warszawa
Portugal Centro Hospitalar de Lisboa Norte, EPE, Hospital de Santa Maria - Reumatologia Lisboa Av. Prof. Egas Moniz
Portugal Centro Hospitalar de Lisboa Ocidental, EPE - Hospital de Egas Moniz, Unidade de Reumatologia Lisboa Rua da Junqueira, 126
Portugal Centro Hospitalar do Porto, EPE - Hospital de Santo Antonio, Departamento de Medicina - Unidade de Imunologia Clinica Porto Largo Prof. Abel Salazar
Portugal Hospital de Sao Jeao, Servico de Nefrologia Porto
Portugal Centro Hospitalar de Vila Nova de Gaia Vila Nova de Gaia Rua Conceicao Fernandes
Puerto Rico RCMI Clinical Research Center, 1st Floor University Hospital Medical Center San Juan
Romania "Ion Stoia" Center of Rheumatic Diseases Bucharest
Romania "Sf. Maria" Clinical Hospital Bucharest
Romania Emergency Clinical County Hospital Cluj Cluj Napoca
Romania Rehabilitation Clinical Hospital Iasi
Serbia Institute of Nephrology and Urology Clinical Centre of Serbia Belgrade
Serbia Institute of Rheumatology Belgrade
Serbia University Medical Centre "Zvezdara", Clinical Department for Renal Diseases, Dimitrija Tucovica 161 Belgrade
Serbia Institute of Prevention, Treatment and Rehabilitation of Rheumatoid and Cardiovascular Patients "Niska Banja" Niska Banja
Slovakia Reumatologicka ambulancia Fakultna nemocnica F D Roosevelta Banska Bystrica
Slovakia Reumatologicka ambulancia Fakultna nemocnica s poliklinikou Milosrdni bratia spol s r o Bratislava
Spain Hospital Clinic i Provincial de Barcelona, Centre Ciutat, Facultat de Medicina, Servicio de Enfermedades Autoinmunes Barcelona Calle Villarroel, 170
Spain Hospital Universitari Vall d'Hebron, Servicia Medicina Interna, Edificio General, 3a Planta Barcelona Paseo Valle de Hebron 119-129
Spain Hospital Universitario La Paz, Servico de Medicine Interne Planta 10 Madrid Paseo de la Castellana 261
Sri Lanka University Lupus Clinic of the Department of Clinical Medicine, Faculty of Medicine, University of Colombo, P.O. Box 271, No 25, Colombo Kynsey Road
Taiwan Buddhist Dalin Tzu Chi General Hospital, Vice Superintendent Room Dalin Town Chia-Yi county
Taiwan Kaohsiung University Medical Hospital Kaohsiung
Taiwan Kaohsiung Veterans General Hospital Kaohsiung
Taiwan Chang Gung Memorial Hospital Kaohsiung Hsien
Taiwan Chang Gung Memorial Hospital - Keelung Keelung city
Taiwan China Medical University Hospital Taichung
Taiwan Chung Shan Medical University Hospital Taichung City
Taiwan National Chang-Kung University Hospital Tainan
Taiwan Chang Gung Memorial Hospital - Taipei Taipei
Taiwan Taipei Veterans General Hospital - Immunology & Rheumatology Office Taipei
Taiwan Chang Gung Memorial Hospital Taoyuan
Taiwan Chi Mei Foundation Hospital Yongkang City
Thailand Department of Medicine, King Chulalongkorn Memorial Hospital Bangkok
Thailand Ramathibodi Hospital - Division of Allergy, Immunology & Rheumatology, Dept. of Medicine Bangkok
Thailand Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine Bangkok
Ukraine Donetsk Central Municipal Clinical Hospital #1 Donetsk
Ukraine Kyiv Central Municipal Clinical Hospital Kyiv
Ukraine Kyiv Regional Clinical Hospital Kyiv
Ukraine M.D. Strazhesko Institute of Cardiology AMS Ukraine Kyiv
Ukraine Lviv Municipal Public Clinical Hospital Lviv
Ukraine Vinnitsa Regional Clinical Hospital of MoH of Ukraine Vinnitsa
United States Amarillo Center for Clinical Research Amarillo Texas
United States Emory University School of Medicine, Renal Division Atlanta Georgia
United States Private Practice Augusta Georgia
United States University of Alabama at Birmingham Birmingham Alabama
United States Intermountain Orthopedics Boise Idaho
United States Private Practice Camp Hill Pennsylvania
United States Rheumatology Associates Chicago Illinois
United States Ohio State University Medical Center Columbus Ohio
United States Altoona Center for Clinical Research Duncansville Pennsylvania
United States Clinical Research & Consulting Center Fairfax Virginia
United States Nephrology Associates, PC Flushing New York
United States CRIA Research Fort Lauderdale Florida
United States SOMARC Trials, LLC Greenbelt Maryland
United States Miracle Medical Clinic, 1170 Blalock Road Houston Texas
United States Renal Care Clinic, P.A., 17202 Red Oak Drive Houston Texas
United States Arthritis Clinic, 371 North Parkway, Suite 400 Jackson Tennessee
United States North Shore - LIJ Health System Lake Success New York
United States Wallace Rheumatic Study Center Los Angeles California
United States Texas Tech University Health Sciences Center Lubbock Texas
United States Feinstein Institute for Medical Research Manhasset New York
United States Miami Children's Hospital Miami Florida
United States Ochsner Clinic Foundation New Orleans Louisiana
United States Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases New York New York
United States AAIR Research Center Rochester New York
United States San Antonio Kidney Disease Center San Antonio Texas
United States East Bay Rheumatology Medical Group San Leandro California
United States Private Practice San Mateo California
United States Southeast Regional Research Group Savannah Georgia
United States Arthritis Northwest PLLC Spokane Washington
United States Suny Upstate Medical University Syracuse New York
United States Healthcare Research Consultants Tulsa Oklahoma
United States Wake Forest University Health Sciences Winston Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
La Jolla Pharmaceutical Company

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Belarus,  Brazil,  Bulgaria,  Czech Republic,  Georgia,  Germany,  Hong Kong,  Hungary,  India,  Indonesia,  Italy,  Korea, Republic of,  Lebanon,  Malaysia,  Mexico,  Philippines,  Poland,  Portugal,  Puerto Rico,  Romania,  Serbia,  Slovakia,  Spain,  Sri Lanka,  Taiwan,  Thailand,  Ukraine, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine whether abetimus sodium is more effective than placebo in delaying the time to renal flare in SLE patients with a history of SLE renal disease. Weekly administration with a 52-week treatment duration. Time to event (12 months fixed treatment duration) Yes
Secondary To determine whether treatment with abetimus sodium is more effective than placebo in delaying the time to Major SLE flare; and to determine whether treatment with abetimus sodium (LJP 394) is more effective than placebo in reducing proteinuria. 12 month fixed treatment duration Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02936375 - The Iguratimod Effect on Lupus Nephritis (IGeLU) Phase 2
Completed NCT03597464 - Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin Phase 3
Recruiting NCT01226147 - Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis Phase 2
Completed NCT01206569 - Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis Phase 4
Active, not recruiting NCT00569101 - A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis Phase 2
Terminated NCT00368264 - TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) Phase 2/Phase 3
Completed NCT00298506 - Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V) N/A
Completed NCT00371319 - Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis Phase 4
Completed NCT00094380 - Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) Phase 1/Phase 2
Terminated NCT04376827 - A Study of Guselkumab in Participants With Active Lupus Nephritis Phase 2
Completed NCT03610516 - Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. Phase 2
Recruiting NCT03526042 - Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis N/A
Withdrawn NCT03859570 - Pentoxifylline in Lupus Nephritis Phase 4
Completed NCT03664908 - Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)? N/A
Completed NCT01085097 - A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis Phase 2
Active, not recruiting NCT05704088 - SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients Phase 4
Not yet recruiting NCT06429800 - A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Lupus Nephritis Phase 1
Recruiting NCT02226341 - ACTHar in the Treatment of Lupus Nephritis Phase 4
Recruiting NCT02453997 - Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis N/A
Completed NCT01470183 - Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients N/A

External Links